Home › Compare › CLBS vs YUM

CLBS vs YUM: Dividend Comparison 2026

CLBS yields 131.33% · YUM yields 1.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CLBS wins by $12.89M in total portfolio value
10 years
CLBS
CLBS
● Live price
131.33%
Share price
$0.43
Annual div
$0.56
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$12.99M
Annual income
$5,201,713.69
Full CLBS calculator →
YUM
YUM
● Live price
1.85%
Share price
$155.48
Annual div
$2.88
5Y div CAGR
51.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$107.0K
Annual income
$39,957.33
Full YUM calculator →

Portfolio growth — CLBS vs YUM

📍 CLBS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCLBSYUM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CLBS + YUM cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
CLBS pays
YUM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CLBS
Annual income on $10K today (after 15% tax)
$11,163.23/yr
After 10yr DRIP, annual income (after tax)
$4,421,456.64/yr
YUM
Annual income on $10K today (after 15% tax)
$157.45/yr
After 10yr DRIP, annual income (after tax)
$33,963.73/yr
At 15% tax rate, CLBS beats the other by $4,387,492.91/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CLBS + YUM for your $10,000?

CLBS: 50%YUM: 50%
100% YUM50/50100% CLBS
Portfolio after 10yr
$6.55M
Annual income
$2,620,835.50/yr
Blended yield
40.01%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on YUM right now

CLBS
No analyst data
Altman Z
-42.9
Piotroski
2/9
YUM
Analyst Ratings
18
Buy
30
Hold
3
Sell
Consensus: Hold
Price Target
$173.15
+11.4% upside vs current
Range: $158.00 — $190.00
Altman Z
2.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CLBS buys
0
YUM buys
0
No recent congressional trades found for CLBS or YUM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCLBSYUM
Forward yield131.33% ✓1.85%
Annual dividend / share$0.56$2.88 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.4% ✓
Portfolio after 10y$12.99M$107.0K ✓
Annual income after 10y$5,201,713.69 ✓$39,957.33
Total dividends collected$11.90M$80.4K ✓
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: CLBS vs YUM ($10,000, DRIP)

YearCLBS PortfolioCLBS Income/yrYUM PortfolioYUM Income/yrGap
1← crossover$23,833$13,133.21$10,980$280.44+$12.9K → CLBS
2$54,754$29,252.94$12,185$435.72+$42.6K → CLBS
3$121,396$62,809.15$13,722$684.14+$107.7K → CLBS
4$260,039$130,144.39$15,773$1,090.14+$244.3K → CLBS
5$538,781$260,539.45$18,650$1,773.02+$520.1K → CLBS
6$1,080,999$504,503.28$22,921$2,966.37+$1.06M → CLBS
7$2,102,673$946,004.75$29,685$5,158.69+$2.07M → CLBS
8$3,969,574$1,719,713.85$41,216$9,453.02+$3.93M → CLBS
9$7,281,647$3,034,202.37$62,672$18,571.31+$7.22M → CLBS
10$12,993,076$5,201,713.69$107,016$39,957.33+$12.89M → CLBS

CLBS vs YUM: Complete Analysis 2026

CLBS — Stock

Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy for the treatment of pre-dialysis patients with chronic kidney disease. The company was formerly known as NeoStem, Inc. and changed its name to Caladrius Biosciences, Inc. in June 2015. Caladrius Biosciences, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.

Full CLBS Calculator →

YUM — Consumer Discretionary

YUM! Brands, Inc., together with its subsidiaries, develops, operates, and franchises quick service restaurants worldwide. It operates through four segments: the KFC Division, the Taco Bell Division, the Pizza Hut Division, and the Habit Burger Grill Division. The company operates restaurants under the KFC, Pizza Hut, Taco Bell, and The Habit Burger Grill brands, which specialize in chicken, pizza, made-to-order chargrilled burgers, sandwiches, Mexican-style food categories, and other food products. As of December 31, 2021, it had 26,934 KFC units; 18,381 Pizza Hut units; 7,791 Taco Bell units; and 318 The Habit Burger Grill units in approximately 157 countries and territories. The company was formerly known as TRICON Global Restaurants, Inc. and changed its name to YUM! Brands, Inc. in May 2002. YUM! Brands, Inc. was incorporated in 1997 and is headquartered in Louisville, Kentucky.

Full YUM Calculator →
📬

Get this CLBS vs YUM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CLBS vs SCHDCLBS vs JEPICLBS vs OCLBS vs KOCLBS vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.